We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.
In cooperation with Association of Corporate Counsel
  Request new password

Search results

Order by most recent / most popular / relevance

Results: 1-10 of 17,551

Patents found obvious; subsequent appeal moot

  • Norton Rose Fulbright Canada LLP
  • -
  • Canada
  • -
  • March 6 2015

Janssen Inc (Janssen) brought two Applications pursuant to section 6 of the Patented Medicines (Notice of Compliance) Regulations for orders

Swiss form second medical use patent claims: a tale of two cities

  • Baker & McKenzie
  • -
  • Netherlands, United Kingdom
  • -
  • March 6 2015

The English and Dutch Courts have recently explored whether the sale of a generic medicine for a non-Patented use (a so-called "skinny label"

Strong Patents Act would fix micro entity gap

  • Foley & Lardner LLP
  • -
  • USA
  • -
  • March 5 2015

Senator Coons (D-Del) has introduced patent reform legislation that is similar to but different from the Goodlatte Innovation Act pending in the

Reforms to be made to UK groundless threats rules

  • Gilbert + Tobin
  • -
  • Australia, United Kingdom
  • -
  • March 5 2015

The UK government has outlined measures to reform the groundless threats regime, responding to proposals published by the Law Commission last year

The agony of anticipation: when will a prior disclosure mean a patent is invalid?

  • Clayton Utz
  • -
  • Australia
  • -
  • March 5 2015

Inevitability is often associated with death and taxes. Something is "inevitable" only when there can be no other outcome. In a recent decision, the

Australia gets compulsory patent licensing laws for pharmaceutical exports to developing countries

  • Clayton Utz
  • -
  • Australia
  • -
  • March 5 2015

In 2005, an international agreement was reached to empower domestic courts to grant compulsory licences for the manufacture of Patented

Single application and examination processes for Australia and New Zealand

  • Spruson & Ferguson
  • -
  • Australia, New Zealand
  • -
  • March 4 2015

As briefly discussed in our previous article, the Australian and New Zealand governments have been working on implementing a single patent

Senate Democrats propose bill to gut AIA trials

  • OBLON
  • -
  • USA
  • -
  • March 4 2015

Well, if you expected the Goodlatte Bill to sail through the House for swift passage through the Senate, forget about it. Hill chatter has indicated

The future of FRAND defence after the Advocate General's opinion in case C-17013 (Huawei Technologies)

  • Taylor Wessing
  • -
  • European Union
  • -
  • March 4 2015

On 20 November 2014 the Advocate General (AG) delivered his opinion when and to what extent exercising FRAND committed SEPs can constitute an abusive

Infringement of second medical use patents

  • Taylor Wessing
  • -
  • Germany, United Kingdom
  • -
  • March 4 2015

With the increase in off-label prescribing in Europe, some argue that the carve-outs used by generic firms (see "Skinny labelling and the blue box